Valiant Navion™ VNMF2222C96TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF2222C96TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000100537), received between Jul 22, 2020 and Sep 23, 2021 — classified as 1 death, 2 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash2
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Death1
- Low Blood Pressure/ Hypotension1
- Rupture1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 23, 2021Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE PATIENT FOR AN ENDOVASCULAR TREATMENT. IT WAS REPORTED THE CORELAB OBSERVED AN UNKNOWN ENDOLEAK ON REVIEW OF FOLLOW UP CTS TAKEN APPROXIMATELY 14 MONTHS POST INDEX PROCEDURE. NO CAUSE OF THE EVENT WAS PROVIDED. NO ADDITIONAL CLINICAL SEQUALAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12518056 ↗MalfunctionSep 7, 2021Leak/Splash; Leak/Splash
A VALIANT NAVION WAS IMPLANTED IN THE PATIENT FOR A TEVAR TREATMENT . APPROXIMATELY 14 MONTHS POST INDEX PROCEDURE, IT WAS REPORTED THE CORELAB OBSERVED AN UNKNOWN ENDOLEAK ON CT. IT WAS ADDITIONALLY REPORTED THERE WAS NO STENT RING ENLARGEMENT OR FRACTURES OBSERVED. NO CAUSE OF THE EVENT HAS BEEN REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12432854 ↗DeathJul 22, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN OPEN SURGICAL GRAFT THAT HAD BEGUN TO DEGENERATE. IT WAS REPORTED THAT DURING THE DELIVERY OF THE STENT GRAFT VNMF2222C96TU, THE PATIENTS BLOOD PRESSURE SUDDENLY DROPPED. IT WAS INDICATED THAT THE PATIENT'S AORTA RUPTURED DURING THE PROCEDURE. IT WAS STATED THAT THE VALIANT NAVION VNMC2222C94TU WAS ATTEMPTED TO BE IMPLANTED BUT WASN'T, DUE TO AN UNKNOWN REASON. ANOTHER VALIANT NAVION WAS SUCCESSFULLY IMPLANTED TO TREAT THE RUPTURED AORTA. IT WAS REPORTED THAT THE PATIENT EXPIRED THE NEXT DAY. IT WAS REPORTED THERE WASN'T A RELATIONSHIP BETWEEN THE RUPTURE OCCURRING AND ANY SPECIFIC DEVICE USED DURING THE PROCEDURE NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS EXPIRED.
Patient problems: Death; Low Blood Pressure/ Hypotension; Rupture
MAUDE report 10306812 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page